|
시장보고서
상품코드
1388051
세균 항원 시장 점유율, 규모, 동향, 산업 분석 보고서 : 항원 유형별, 진단 기술별, 최종사용자별, 지역별, 부문별 예측(2023-2032년)Bacterial Antigens Market Share, Size, Trends, Industry Analysis Report, By Antigen Type ; By Diagnostic Techniques; By End User; By Region; Segment Forecast, 2023 - 2032 |
||||||
Polaris market research의 최신 조사에 따르면, 세계 세균 항원 시장 규모는 2032년까지 2,009만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
전 세계 전염병 부담의 지속적인 증가, 효과적인 진단 및 치료 솔루션의 광범위한 도입 및 필요성, 예방 접종의 중요성에 대한 사람들의 인식 증가, 제형에 세균 항원이 필요한 새로운 백신 개발의 증가는 시장 수요와 성장을 촉진하는 주요 요인입니다.
또한, 바이오 제조 공정의 지속적인 개선으로 세균 항원의 보다 효율적이고 비용 효율적인 생산이 가능해졌고, 특히 개발도상국에서 백신과 진단 도구의 접근성이 향상되면서 항원의 특성과 능력의 혁신에 초점을 맞춘 연구 개발 활동에 대한 투자가 증가하고 있어 가까운 장래에 제품 수요를 촉진할 가능성이 높습니다.
예를 들어, 2023년 5월 에벡시온은 바이러스, 박테리아 및 암 백신의 전체 면역 반응을 향상시키는 새로운 보조제 기술을 발표했습니다. 이 기술은 또한 바이러스와 세균 항원 모두에 대한 중화 항체와 T 세포 반응을 유도합니다.
다양한 보이지 않는 인구통계학적 및 역학적 추세로 인해 특히 신흥 경제권에서 의료비 지출이 지속적으로 확대되고 있으며, 자유화된 외국인 투자 기준, 의료기기 공원 및 정책, 전용 벌크 의약품 설치에 대한 우대 조치 등 여러 정책적 요인에 의해 크게 뒷받침되고 있기 때문에 세균 항원이 의료 환경에서 채택되고 사용되는 기회는 전 세계적으로 유리할 것으로 보입니다.
이 외에도, 특히 자원이 제한된 환경에서 신속하고 정확한 현장 진단 검사에 대한 수요가 증가하고 있으며, 병원 및 진단 연구소를 포함한 다양한 의료 환경에서 쉽게 배포하고 사용할 수 있는 세균 항원 기반 검사 개발이 확산되고 있어, 시장에서 사업을 운영하는 기업들에게 큰 수익 창출의 길이 열리고 있습니다.
세균 항원 시장 보고서 하이라이트
클로스트리디움 디피실 톡소이드 A(Clostridium difficile toxoid A) 분야가 가장 큰 점유율을 차지했는데, 이는 주로 의료 환경에서의 세균 감염 증가에 기인합니다.
전 세계적으로 면역 측정 기술의 발전으로 면역 측정 분야가 가장 큰 점유율을 차지하고 있습니다.
학술 및 연구기관 분야는 항원의 다양한 측면을 연구하기 위해 연구기관에서 세균 항원에 대한 수요가 증가함에 따라 가장 빠른 속도로 성장할 것입니다.
북미 지역이 세계 시장을 장악하고 있으며, 이는 정부의 우호적인 이니셔티브가 급증하고 사람들의 인식이 높아졌기 때문입니다.
주요 시장 기업은 Ross Southern Laboratories, Thermo Fisher Scientific, The Native Antigen Company, Enzo Life Sciences, Creative Diagnostics 등입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 세균 항원 시장에 관한 인사이트
- 세균 항원 시장 - 최종사용자 현황
- 세균 항원 시장 역학
- 성장 촉진요인과 기회
- 다양한 종류의 세균 항원 사용이 증가
- 백신 접종의 중요성에 대한 인식 확산
- 성장 억제요인과 과제
- 세균 항원의 복잡성과 다양성
- 성장 촉진요인과 기회
- PESTEL 분석
- 세균 항원 시장 최종사용자 동향
- 밸류체인 분석
- COVID-19 감염증의 영향 분석
제5장 항원 유형별 : 세계의 세균 항원 시장
- 주요 조사 결과
- 서론
- 클로스트리듐 디피실 톡소이드 A
- 클로스트리듐 디피실 톡소이드 B
- 클라미디아 트라코마티스
- 천연 리포테이코산
- 질 트리코모나스
- 기타
제6장 진단 기술별 : 세계의 세균 항원 시장
- 주요 조사 결과
- 서론
- ELISA
- 면역측정법
- SDS-PAGE
- 혈구 응집
- 응집 시험
- 기타 진단 방법
제7장 최종사용자별 : 세계의 세균 항원 시장
- 주요 조사 결과
- 서론
- 진단 연구소 및 센터
- 학술연구기관
- 병원
제8장 지역별 : 세계의 세균 항원 시장
- 주요 조사 결과
- 서론
- 세균 항원 시장 평가, 지역별, 2019-2032년
- 세균 항원 시장 - 북미
- 북미 : 세균 항원 시장, 항원 유형별, 2019-2032년
- 북미 : 세균 항원 시장, 최종사용자별, 2019-2032년
- 북미 : 세균 항원 시장, 진단 기술별, 2019-2032년
- 세균 항원 시장 - 미국
- 세균 항원 시장 - 캐나다
- 세균 항원 시장 - 유럽
- 유럽 : 세균 항원 시장, 항원 유형별, 2019-2032년
- 유럽 : 세균 항원 시장, 최종사용자별, 2019-2032년
- 유럽 : 세균 항원 시장, 진단 기술별, 2019-2032년
- 세균 항원 시장 - 영국
- 세균 항원 시장 - 프랑스
- 세균 항원 시장 - 독일
- 세균 항원 시장 - 이탈리아
- 세균 항원 시장 - 스페인
- 세균 항원 시장 - 네델란드
- 세균 항원 시장 - 러시아
- 세균 항원 시장 - 아시아태평양
- 아시아태평양 : 세균 항원 시장, 항원 유형별, 2019-2032년
- 아시아태평양 : 세균 항원 시장, 최종사용자별, 2019-2032년
- 아시아태평양 : 세균 항원 시장, 진단 기술별, 2019-2032년
- 세균 항원 시장 - 중국
- 세균 항원 시장 - 인도
- 세균 항원 시장 - 말레이시아
- 세균 항원 시장 - 일본
- 세균 항원 시장 - 인도네시아
- 세균 항원 시장 - 한국
- 세균 항원 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 세균 항원 시장, 항원 유형별, 2019-2032년
- 중동 및 아프리카 : 세균 항원 시장, 최종사용자별, 2019-2032년
- 중동 및 아프리카 : 세균 항원 시장, 진단 기술별, 2019-2032년
- 세균 항원 시장 - 사우디아라비아
- 세균 항원 시장 - 아랍에미리트
- 세균 항원 시장 - 이스라엘
- 세균 항원 시장 - 남아프리카공화국
- 세균 항원 시장 - 라틴아메리카
- 라틴아메리카 : 세균 항원 시장, 항원 유형별, 2019-2032년
- 라틴아메리카 : 세균 항원 시장, 최종사용자별, 2019-2032년
- 라틴아메리카 : 세균 항원 시장, 진단 기술별, 2019-2032년
- 세균 항원 시장 - 멕시코
- 세균 항원 시장 - 브라질
- 세균 항원 시장 - 아르헨티나
제9장 경쟁 상황
- 확장과 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Becton
- Dickinson and Company
- BioFire Diagnostics
- Creative Diagnostics
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- LGC Bioresearch Technologies
- Merck & Co. Inc.
- QED Bioscience Inc.
- Ross Southern Laboratories
- Synthetic Genomics
- The Native Antigen Company Ltd.
- Thermo Fisher Scientific
- ZeptoMetrix Corporation
The global bacterial antigens market size is expected to reach USD 20.09 million by 2032, according to a new study by Polaris market research. The report "Bacterial Antigens Market Share, Size, Trends, Industry Analysis Report, By Antigen Type (Clostridium Difficile Toxoid A, Clostridium Difficile B, Chlamydia Trachomatis, Native Lipoteichoic Acid, Trichomonas Vaginalis, and Others); By Diagnostic Techniques; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The constant increase in the burden of infectious diseases globally and widespread adoption and need for effective diagnostic and therapeutic solutions, along with the growing people awareness towards the importance of vaccinations and the rising number of new vaccine developments that require bacterial antigens for their formulations, are major prominent factors boosting the market demand and growth.
Furthermore, ongoing improvements in biomanufacturing processes could lead to more efficient and cost-effective production of bacterial antigens while enhancing the accessibility of vaccines and diagnostic tools, particularly in developing countries and growing investments in research development activities focused on innovating antigens features and capabilities, will likely to propel the product demand in the near future.
For instance, in May 2023, Evaxion unveiled a new adjuvant technology that boosts the overall immune response of viral, bacterial, and cancer vaccines. This technology also induces neutralizing antibodies and T-cell responses against both viral and bacterial antigens.
With the continuous expansion in healthcare expenditure, especially in emerging economies due to various invisible demographic and epidemiologic trends, that are significantly supported by several policy factors like liberalized foreign investment norms, medical devices parks and regulations, and incentives for setting up dedicated bulk-drug, there will be lucrative opportunities for bacterial antigens to be adopted and used in healthcare settings globally.
Besides this, there has been increasing demand for rapid and accurate point-of-care diagnostic tests, particularly in resource-limited settings, and greater prevalence for developing bacterial antigen-based tests that are easy to deploy and use in various healthcare settings, including hospitals and diagnostic laboratories, and have paved the way for significant revenue opportunities for companies operating in the market.
Bacterial Antigens Market Report Highlights
Clostridium difficile toxoid A segment accounted for largest share, mainly due to rising incidences of bacterial infections into the healthcare settings
Immunoassay segment held the maximum share, on account of increasing advancements in immunoassay technologies globally
Academic & research institutes segment will grow at fastest pace, because of the rising need for bacterial antigens in research institutes to study different aspects of antigens
North America region dominated the global market, owing to surge in the number of favorable government initiatives and higher awareness among people
The key market players include Ross Southern Laboratories, Thermo Fisher Scientific, The Native Antigen Company, Enzo Life Sciences, and Creative Diagnostics
Polaris market research has segmented the bacterial antigens market report based on antigen type, diagnostic techniques, end user, and region:
Bacterial Antigens, Antigen Type Outlook (Revenue - USD Million, 2019 - 2032)
- Clostridium Difficile Toxoid A
- Clostridium Difficile B
- Chlamydia Trachomatis
- Native Lipoteichoic Acid
- Trichomonas Vaginalis
- Others
Bacterial Antigens, Diagnostic Techniques Outlook (Revenue - USD Million, 2019 - 2032)
- ELISA
- Immunoassay
- SDS-PAGE
- Hemagglutination
- Agglutination Test
- Others
Bacterial Antigens, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Diagnostic Laboratories and Centers
- Academic Research Institutes
- Hospital
Bacterial Antigens, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Bacterial Antigens Market Insights
- 4.1. Bacterial Antigens Market - End User Snapshot
- 4.2. Bacterial Antigens Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing use of different types of bacterial antigens
- 4.2.1.2. Rising awareness regarding the importance of vaccinations
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Complexity and variability of bacterial antigens
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Bacterial Antigens Market End User Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Bacterial Antigens Market, by Antigen Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 5.3. Clostridium Difficile Toxoid A
- 5.3.1. Global Bacterial Antigens Market, by Clostridium Difficile Toxoid A, by Region, 2019-2032 (USD Million)
- 5.4. Clostridium Difficile Toxoid B
- 5.4.1. Global Bacterial Antigens Market, by Clostridium Difficile Toxoid B, by Region, 2019-2032 (USD Million)
- 5.5. Chlamydia Trachomatis
- 5.5.1. Global Bacterial Antigens Market, by Chlamydia Trachomatis, by Region, 2019-2032 (USD Million)
- 5.6. Native Lipoteichoic Acid
- 5.6.1. Global Bacterial Antigens Market, by Native Lipoteichoic Acid, by Region, 2019-2032 (USD Million)
- 5.7. Trichomonas Vaginalis
- 5.7.1. Global Bacterial Antigens Market, by Trichomonas Vaginalis, by Region, 2019-2032 (USD Million)
- 5.8. Others
- 5.8.1. Global Bacterial Antigens Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Bacterial Antigens Market, by Diagnostic Techniques
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 6.3. ELISA
- 6.3.1. Global Bacterial Antigens Market, by ELISA, by Region, 2019-2032 (USD Million)
- 6.4. Immunoassay
- 6.4.1. Global Bacterial Antigens Market, by Immunoassay, by Region, 2019-2032 (USD Million)
- 6.5. SDS-PAGE
- 6.5.1. Global Bacterial Antigens Market, by SDS-PAGE, by Region, 2019-2032 (USD Million)
- 6.6. Hemagglutination
- 6.6.1. Global Bacterial Antigens Market, by Hemagglutination, by Region, 2019-2032 (USD Million)
- 6.7. Agglutination Test
- 6.7.1. Global Bacterial Antigens Market, by Agglutination Test, by Region, 2019-2032 (USD Million)
- 6.8. Other Diagnostic Techniques
- 6.8.1. Global Bacterial Antigens Market, by Other Diagnostic Techniques, by Region, 2019-2032 (USD Million)
7. Global Bacterial Antigens Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 7.3. Diagnostic Laboratories and Centers
- 7.3.1. Global Bacterial Antigens Market, by Diagnostic Laboratories and Centers, By Region, 2019-2032 (USD Million)
- 7.4. Academic and Research Institutes
- 7.4.1. Global Bacterial Antigens Market, by Academic and Research Institutes, By Region, 2019-2032 (USD Million)
- 7.5. Hospital
- 7.5.1. Global Bacterial Antigens Market, by Hospital, By Region, 2019-2032 (USD Million)
8. Global Bacterial Antigens Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Bacterial Antigens Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Bacterial Antigens Market - North America
- 8.3.1. North America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.3.2. North America: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.3.3. North America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.3.4. Bacterial Antigens Market - U.S.
- 8.3.4.1. U.S.: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.3.5. Bacterial Antigens Market - Canada
- 8.3.5.1. Canada: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4. Bacterial Antigens Market - Europe
- 8.4.1. Europe: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.3. Europe: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.4. Bacterial Antigens Market - UK
- 8.4.4.1. UK: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.4.3. UK: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.5. Bacterial Antigens Market - France
- 8.4.5.1. France: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.5.3. France: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.6. Bacterial Antigens Market - Germany
- 8.4.6.1. Germany: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.7. Bacterial Antigens Market - Italy
- 8.4.7.1. Italy: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.8. Bacterial Antigens Market - Spain
- 8.4.8.1. Spain: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.9. Bacterial Antigens Market - Netherlands
- 8.4.9.1. Netherlands: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.4.10. Bacterial Antigens Market - Russia
- 8.4.10.1. Russia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5. Bacterial Antigens Market - Asia Pacific
- 8.5.1. Asia Pacific: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.4. Bacterial Antigens Market - China
- 8.5.4.1. China: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.4.3. China: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.5. Bacterial Antigens Market - India
- 8.5.5.1. India: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.5.3. India: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.6. Bacterial Antigens Market - Malaysia
- 8.5.6.1. Malaysia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.7. Bacterial Antigens Market - Japan
- 8.5.7.1. Japan: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.8. Bacterial Antigens Market - Indonesia
- 8.5.8.1. Indonesia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.5.9. Bacterial Antigens Market - South Korea
- 8.5.9.1. South Korea: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.6. Bacterial Antigens Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.6.4. Bacterial Antigens Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.6.5. Bacterial Antigens Market - UAE
- 8.6.5.1. UAE: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.6.6. Bacterial Antigens Market - Israel
- 8.6.6.1. Israel: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.6.7. Bacterial Antigens Market - South Africa
- 8.6.7.1. South Africa: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.7. Bacterial Antigens Market - Latin America
- 8.7.1. Latin America: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.7.4. Bacterial Antigens Market - Mexico
- 8.7.4.1. Mexico: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.7.5. Bacterial Antigens Market - Brazil
- 8.7.5.1. Brazil: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
- 8.7.6. Bacterial Antigens Market - Argentina
- 8.7.6.1. Argentina: Bacterial Antigens Market, by Antigen Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Bacterial Antigens Market, by End User, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Bacterial Antigens Market, by Diagnostic Techniques, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Becton
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Dickinson and Company
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BioFire Diagnostics
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Creative Diagnostics
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Enzo Life Sciences Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Jena Bioscience GmbH
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. LGC Bioresearch Technologies
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Merck & Co. Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. QED Bioscience Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Ross Southern Laboratories
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Synthetic Genomics
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. The Native Antigen Company Ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Thermo Fisher Scientific
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. ZeptoMetrix Corporation
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
